New label restrictions and boxed warning on clofibrate.
D002994:Clofibrate / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D006949:Hyperlipidemias / Q000401:mortality / Q000628:therapy; D014481:United States; D014486:United States Food and Drug Administration
D002994:Clofibrate